“…In all participants, the total EPC count was assessed by using an in vitro assay, as described previously. 8) In brief, mononuclear cells (MNCs) were obtained from peripheral blood samples (100 µL), and the EPCs were identified by flow cytometry (BD Biosciences, San Jose, CA, USA). Their phenotype was determined by immunohistochemistry after staining with 20 µL fluorescein PE-Cy5-conjugated anti-CD45 monoclonal antibody (Dynona, Korea), 20 µL of fluorescein isothiocyanate (FITC)-conjugated anti-CD34 monoclonal antibody (Dynona, Korea) and 10 µL of PE-conjugated anti-vascular endothelial growth factor receptor 2 (VEGFR2) monoclonal antibody (R&D, Minneapolis, MN, USA), and further incubated in a dark room for 1 hour.…”